BlackRock, Inc.

Position in LNTH — Lantheus Holdings, Inc.

CIK 2012383 New York, NY

Position in LNTH

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$620,695,182

+$70,565,339 QoQ

Shares Held

8,183,193

-1.0% QoQ

Ownership

12.6%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 97.02466995462528.ToString("F0")% Shared 0.ToString("F0")% None 2.975330045374709.ToString("F0")%

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $19,747,889,781 across 67 Drug Manufacturers - Specialty & Generic names. LNTH ranks #8 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	35,584,312	$4,206,421,510
2	UTHR	UNITED THERAPEUTICS Corp	5,399,649	$3,201,883,855
3	TEVA	Teva Pharmaceutical Industries Ltd	65,136,464	$1,961,910,288
4	NBIX	Neurocrine Biosciences Inc	13,385,607	$1,763,419,854
5	VTRS	Viatris Inc	84,359,804	$1,139,700,941
6	ELAN	Elanco Animal Health Inc	47,622,630	$1,139,609,527
7	ALKS	Alkermes plc.	28,314,410	$1,001,197,527
8	LNTH	Lantheus Holdings, Inc. This page	8,183,193	$620,695,182

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$620,695,182	8,183,193	-1.0%	Shares	Sole	2026-05-13
2025-12-31	$550,129,843	8,266,414	+0.0%	Shares	Sole	2026-02-12
2025-09-30	$423,950,054	8,265,745	-3.1%	Shares	Sole	2025-11-12
2025-06-30	$698,546,980	8,533,435	-2.5%	Shares	Sole	2025-08-12
2025-03-31	$854,442,411	8,754,533	+1.6%	Shares	Sole	2025-05-02
2024-12-31	$770,696,907	8,614,989	+0.9%	Shares	Sole	2025-02-07
2024-09-30	$936,915,442	8,536,815	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.